Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 8/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.31 |
| ▸ | TP53 | P04637 | 2/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL374775 | 0.93 | TSHR (0.38) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL3478417 | 0.90 | TSHR (0.33) | TSHRHPGD | |
| SCHEMBL3832655 | 0.87 | TSHR (0.36) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL139100 | 0.86 | TSHR (0.35) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL5838258 | 0.85 | TSHR (0.39) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL2359477 | 0.84 | TSHR (0.38) | TSHRHPGD | |
| SCHEMBL9788927 | 0.83 | TSHR (0.33) | TSHRHPGD | |
| SCHEMBL9245895 | 0.82 | TSHR (0.32) | TSHRHPGD | |
| SCHEMBL1717354 | 0.82 | TSHR (0.38) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL5839195 | 0.82 | TSHR (0.38) | TSHRHPGDALDH1A1TP53HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260049184-A1 | CURABLE COMPOSITION AND INK FOR INK-JET PRINTING | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-02-19 | — | — | US | disclosed |
| US-20230049921-A1 | CURABLE COMPOSITION AND INK FOR INK-JET PRINTING | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-02-16 | — | — | US | disclosed |
| EP-4089147-A1 | CURABLE COMPOSITION AND INK FOR INK-JET PRINTING | Shin-Etsu Chemical Co., Ltd. (JP) | 2022-11-16 | — | — | EP | disclosed |
| EP-3178876-B1 | INORGANIC PARTICLE-POLYSILOXANE COMPOSITE, DISPERSION AND SOLID MATERIAL CONTAINING THE COMPOSITE, AND MAKING METHOD | SHINETSU CHEMICAL CO (JP) | 2020-10-21 | — | — | EP | disclosed |
| US-10227453-B2 | Silicone rubber composition and cured product thereof | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2019-03-12 | — | — | US | disclosed |
| EP-3178876-A1 | INORGANIC PARTICLE-POLYSILOXANE COMPOSITE, DISPERSON AND SOLID MATERIAL CONTAINING THE COMPOSITE, AND MAKING METHOD | Shin-Etsu Chemical Co., Ltd. (JP) | 2017-06-14 | — | — | EP | disclosed |
| EP-3178885-A1 | SILICONE RUBBER COMPOSITION AND CURED PRODUCT THEREOF | Shin-Etsu Chemical Co., Ltd. (JP) | 2017-06-14 | — | — | EP | disclosed |
| US-20170158821-A1 | SILICONE RUBBER COMPOSITION AND CURED PRODUCT THEREOF | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-06-08 | — | — | US | disclosed |
| US-20170158859-A1 | INORGANIC PARTICLE-POLYSILOXANE COMPOSITE, DISPERSION AND SOLID MATERIAL CONTAINING THE COMPOSITE, AND MAKING METHOD | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260049184-A1 | CURABLE COMPOSITION AND INK FOR INK-JET PRINTING | SEM1, COL1A1, HTR3D | TSHR 3974/4885HPGD 3457/4885ALDH1A1 772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.